| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Vice President, Accounting | Common Stock | 34,308 | $544,124 | $15.86 | 02 Jan 2026 | Direct |
| Janux Therapeutics, Inc. | Vice President, Accounting | Stock option (right to buy) | 42,600 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | 02 Jan 2026 | 3 | -$20,073 | 4 | Vice President, Accounting | 02 Jan 2026, 21:00 |
| JANX | Janux Therapeutics, Inc. | 02 Jan 2025 | 2 | $0 | 4 | Vice President, Accounting | 03 Jan 2025, 20:10 |
| JANX | Janux Therapeutics, Inc. | 08 Aug 2024 | 0 | $0 | 3 | Vice President, Accounting | 09 Aug 2024, 19:06 |